Radiopharm Theranostics Limited
RDPTF
$0.0113
$0.01051,312.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.64M | -29.25M | -30.73M | -30.46M | -30.37M |
| Total Depreciation and Amortization | 2.03M | 1.53M | 1.02M | 1.61M | 2.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.09M | 4.42M | 10.00M | 12.03M | 14.15M |
| Change in Net Operating Assets | 4.64M | 4.64M | 4.64M | 1.71M | -1.24M |
| Cash from Operations | -22.06M | -18.65M | -15.07M | -15.10M | -15.24M |
| Capital Expenditure | -- | -- | -- | 9.40K | 19.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.98M | 1.00M | -- | -496.10K | -1.00M |
| Cash from Investing | 1.98M | 1.00M | -- | -486.80K | -984.90K |
| Total Debt Issued | 4.40M | 5.89M | 7.37M | 5.17M | 2.97M |
| Total Debt Repaid | -4.10M | -4.63M | -5.17M | -4.07M | -2.97M |
| Issuance of Common Stock | 73.37M | 51.51M | 29.65M | 15.88M | 2.11M |
| Repurchase of Common Stock | -- | -- | -- | -400.00 | -800.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.17M | -5.57M | -1.97M | -1.06M | -152.40K |
| Cash from Financing | 42.56M | 31.28M | 19.66M | 10.46M | 1.28M |
| Foreign Exchange rate Adjustments | 303.00K | 145.50K | -16.40K | 19.50K | 56.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.79M | 13.77M | 4.58M | -5.11M | -14.88M |
